Why is Tatva Chintan falling/rising?

As of 10-Oct, Tatva Chintan Pharma Chem Ltd is experiencing a price increase, currently at Rs 1,072.35, which reflects a rise of Rs 25.3 or 2.42%. The stock has shown strong performance today, outperforming its sector by 2.03% and reaching an intraday high of Rs 1,081, marking a 3.24% increase. Over the past week, the stock has gained 3.00%, and over the past month, it has risen by 6.38%. Additionally, it is trading above all its moving averages, indicating a positive trend. However, there has been a notable decline in investor participation, with delivery volume falling by 32.76% compared to the 5-day average. The company maintains a low debt-to-equity ratio of 0.07, which is favorable for its financial stability. In the broader market context, Tatva Chintan's short-term performance has outpaced the Sensex, which has increased by 1.59% over the same week. Year-to-date, Tatva Chintan has achieved a return of 21.47%, significantly higher than the Sensex's 5.58%. This strong relative performance suggests that investor sentiment towards Tatva Chintan is currently positive, despite the recent drop in trading volume. The majority ownership by promoters may also contribute to stability and confidence in the stock, supporting its upward movement in price.